American company Johnson & Johnson announced that testing of the vaccine against COVID-19 in humans will begin earlier than expected – in the second half of July. Previously, we talked about starting clinical trials no later than September.
Johnson & Johnson began work on the vaccine in January, in May the company said it had agreed with the U.S. authorities to establish production facilities to supply 1 billion doses of the vaccine. The clinical trials of the vaccine will involve 1,045 healthy people between the ages of 18 and 55 and will be tested in the United States and Belgium.
Many pharmaceutical companies are developing a vaccine against COVID-19 – according to WHO, the number of such projects has reached 124, about ten vaccines are already in clinical trials.